Ss Innovations International Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Ss Innovations International Inc (AVMR) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Ss Innovations International Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 52M vs 74,741M combined for tracked competitors (0.1% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+6.8% annualized vs trailing 12 months), vs accelerating (+4.5%) for its tracked peer group.
- Growth: Ss Innovations International Inc generated 39.4% revenue growth year over year in Q2 2026, vs 14.4% for its tracked competitors combined.
- Profitability: Its -19.1% net margin compares with 18.2% for the peer group.
- Peer revenue share: Ss Innovations International Inc accounted for 0.1% of combined revenue among its tracked peer group, up from 0.1% a year earlier.
- Peer differentiation: Revenue per employee of $0.11M compares with $0.44M for the peer group (0.2x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
AVMR Sales vs. its Competitors, Q2 2026
Ss Innovations International Inc reported revenue growth of 39.39 % year on year in Q2 2026, above its competitors' combined revenue growth of 14.44 %.
With a net margin of -19.09 %, Ss Innovations International Inc reported lower profitability than its competitors (18.24 %).
Ss Innovations International Inc generated 0.07 % of the combined sales of its peer group, up from 0.06 % a year earlier.
Ss Innovations International Inc vs. its Competitors, Q2 2026
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Ss Innovations International Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Ss Innovations International Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (3) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (5) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Ss Innovations International Inc's competitor groups requires a Commercial License.
For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs 39.4% for Ss Innovations International Inc. Ss Innovations International Inc's share of combined industry revenue moved from 0.01% to 0.01%, a gain of 0.00 percentage points.
Ss Innovations International Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Ss Innovations International Inc | No | Yes | Yes | No |
| Competitors combined (7) | ||||
| High-Confidence Competitors (5) | ||||
| Similar Growth & Profitability (8) | 12.50 % (1 of 8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 12.50 % (1 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
AVMR Stock Performance relative to its Competitors
AVMR Stock Performance relative to High-Confidence Competitors
AVMR Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Autonomix Medical Inc | 282.9% | Outperformed |
| 2 | Myomo Inc | 282.9% | Outperformed |
| 3 | Ekso Bionics Holdings Inc | 282.9% | Outperformed |
| 4 | Lifeward ltd | 282.9% | Outperformed |
| 5 | Medtronic Plc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Ss Innovations International Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Ss Innovations International Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Ss Innovations International Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Ss Innovations International Inc | - | 52.20 |
| Intuitive Surgical Inc | 148,204.47 | 11,296.30 |
| Medtronic Plc | 115,016.45 | 37,542.00 |
| Stryker Corp | 106,269.66 | 25,837.00 |
| Myomo Inc | 66.61 | 44.24 |
| Ekso Bionics Holdings Inc | 42.04 | 11.11 |
| SUBTOTAL | 369,620.66 | 74,804.68 |
Sign in to see all competitors of Ss Innovations International Inc.
Sources: Ss Innovations International Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Ss Innovations International Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Ss Innovations International Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Intuitive Surgical, Inc. | Named by the company | 85% |
| Titan Medical Inc. | Named by the company | 85% |
| Asensus Surgical, Inc. | Named by the company | 85% |
| Medtronic plc | Named by the company | 85% |
| avateramedical GmbH | Named by the company | 85% |
| Medicaroid Corporation | Named by the company | 85% |
| Samsung Electronics Co., Ltd. | Named by the company | 85% |
| Syneron Medical | Named by the company | 85% |
| meerecompany Inc. | Named by the company | 85% |
| CMR Surgical Ltd. | Named by the company | 85% |
| Medrobotics Corporation | Named by the company | 85% |
| Shandong Weigao Group Medical Polymer Company Ltd. | Named by the company | 85% |
| Johnson & Johnson | Named by the company | 85% |
| Olympus Corporation | Named by the company | 85% |
| Lumenis | Named by the company | 85% |
| Hologic’s Cynosure | Named by the company | 85% |
| Shanghai Microport Medbot (Group) Co., Ltd. | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Ss Innovations International Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Ss Innovations International Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Medtronic Plc | CARDIOVASCULAR 38.34 % |
| Stryker Corp | MedSurg and Neurotechnology 55.02 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Ss Innovations International Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Ss Innovations International Inc | - | 108,071 | -24,835 |
| Intuitive Surgical Inc | 148,204 | 663,668 | 185,530 |
| Medtronic Plc | 115,016 | 395,179 | 55,463 |
| Stryker Corp | 106,270 | 461,375 | 66,589 |
| Myomo Inc | 67 | 226,880 | -74,398 |
| Ekso Bionics Holdings Inc | 42 | 358,484 | -506,097 |
| PEERS TOTAL | 369,621 | 444,088 | 71,757 |
Sign in to see all peers for Ss Innovations International Inc.
Ss Innovations International Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Ss Innovations International Inc | IN 98.66 % |
| Intuitive Surgical Inc | Geographic Distribution, Foreign 30.41 % |
| Medtronic Plc | United States 49.83 % |
| Stryker Corp | United States 75.26 % |
| Lifeward ltd | US 61.35 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Ss Innovations International Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Medical Equipment & Supplies industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (288 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 45.48 % | 53.35 % (avg) | -7.9 pp |
| Operating Margin | -21.07 % | industry median | -12.7 pp |
| EBITDA Margin | -19.36 % | -6.82 % (avg) | -12.5 pp |
| Capital Intensity (Capex / Revenue) | - | 5.43 % (avg) | - |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Ss Innovations International Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | - | - | - | 168.45 % |
| Operating Margin | - | - | -178.85 % | -10.37 % |
| Return on Invested Capital | - | -111.24 % | -82.28 % | -5.28 % |
| P/E | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Ss Innovations International Inc's Strategic Group Map
Every company in Ss Innovations International Inc's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Ss Innovations International Inc is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Ss Innovations International Inc's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Ss Innovations International Inc falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Ss Innovations International Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Latest-quarter revenue run-rate is accelerating (+6.8% annualized vs trailing 12 months).
Weaknesses
- Operating margin 12.7 points below the industry median.
- Return on equity 37.9 points below the industry aggregate.
Opportunities
No rule matched.
Threats
No rule matched.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Ss Innovations International Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Ss Innovations International Inc | 0.37 | 2.23 | 0.26 |
| Intuitive Surgical Inc | 1.43 | 4.80 | - |
| Medtronic Plc | 0.15 | 2.10 | 0.57 |
| Stryker Corp | 0.48 | 1.99 | 0.68 |
| Myomo Inc | 1.37 | 2.68 | 0.97 |
| Ekso Bionics Holdings Inc | 0.39 | 1.76 | 0.34 |
Sign in to see all peers for Ss Innovations International Inc.
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Ss Innovations International Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Ss Innovations International Inc | Q2 2026 | +39.4 % | - |
| Intuitive Surgical Inc | Q2 2026 | +29.3 % | +23.9 % |
| Medtronic Plc | Q2 2026 | +13.7 % | +41.3 % |
| Stryker Corp | Q2 2026 | +9.4 % | +44.3 % |
| Myomo Inc | Q2 2026 | +33.8 % | - |
| Ekso Bionics Holdings Inc | Q1 2026 | -26.1 % | - |
| PEERS TOTAL | +14.5 % | +37.7 % |
Sign in to see all peers for Ss Innovations International Inc.
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Ss Innovations International Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Ss Innovations International Inc | Q2 2026 | +67.4 % | +335,047.9 % |
| Intuitive Surgical Inc | Q2 2026 | +13.4 % | -27.5 % |
| Medtronic Plc | Q2 2026 | +13.8 % | -0.2 % |
| Stryker Corp | Q2 2026 | -4.1 % | +10.4 % |
| Myomo Inc | Q2 2026 | +8.7 % | -93.8 % |
| Ekso Bionics Holdings Inc | Q1 2026 | +29.7 % | - |
Sign in to see all peers for Ss Innovations International Inc.
Ss Innovations International Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Ss Innovations International Inc | - | - | - |
| Intuitive Surgical Inc | 15.63% | 17.11% | 17.82% |
| Medtronic Plc | 5.71% | 6.46% | 10.64% |
| Stryker Corp | 7.89% | 8.80% | 16.36% |
| Myomo Inc | - | - | - |
| Ekso Bionics Holdings Inc | - | - | - |
Sign in to see all peers for Ss Innovations International Inc.
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Ss Innovations International Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Ss Innovations International Inc | - | - |
| Intuitive Surgical Inc | 47.62 | 13.12 |
| Medtronic Plc | 263.24 | 3.06 |
| Stryker Corp | 28.53 | 4.11 |
| Myomo Inc | - | 1.51 |
| Ekso Bionics Holdings Inc | - | 3.78 |
| PEERS AVERAGE | 30.63 | 4.94 |
Sign in to see all peers for Ss Innovations International Inc.
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.